LEGN | Legend Biotech Corporation | 43.98 | 0.24 | +0.55% | 1,520,268 |
INBX | Inhibrx, Inc. | 34.30 | 0.26 | +0.76% | 672,700 |
ANIP | ANI Pharmaceuticals, Inc. | 66.52 | 0.52 | +0.79% | 123,042 |
MRNA | Moderna, Inc. | 111.46 | 1.15 | +1.04% | 3,778,916 |
AMGN | Amgen Inc. | 277.37 | 3.43 | +1.25% | 2,278,372 |
ILMN | Illumina, Inc. | 124.68 | 1.63 | +1.32% | 1,388,477 |
HRMY | Harmony Biosciences Holdings, Inc. | 30.27 | -0.64 | -2.07% | 783,156 |
OLMA | Olema Pharmaceuticals, Inc. | 10.40 | 0.23 | +2.26% | 952,661 |
TWST | Twist Bioscience Corporation | 31.96 | 0.73 | +2.34% | 1,340,606 |
PACB | Pacific Biosciences of California, Inc. | 1.6900 | 0.0400 | +2.42% | 12,255,296 |
MEDP | Medpace Holdings, Inc. | 397.86 | 9.51 | +2.45% | 280,957 |
PHAT | Phathom Pharmaceuticals, Inc. | 9.26 | 0.23 | +2.55% | 512,282 |
ROIV | Roivant Sciences Ltd. | 11.21 | 0.31 | +2.84% | 5,431,363 |
HALO | Halozyme Therapeutics | 39.30 | 1.20 | +3.15% | 1,006,441 |
DAWN | Day One Biopharmaceuticals, Inc. | 17.69 | 0.59 | +3.45% | 1,487,510 |
CNTA | Centessa Pharmaceuticals plc | 9.48 | 0.32 | +3.49% | 231,954 |
INSM | Insmed Incorporated | 25.59 | 0.87 | +3.52% | 1,426,909 |
EXAI | Exscientia plc | 5.14 | 0.19 | +3.84% | 717,395 |
ALEC | Alector, Inc. | 5.28 | 0.20 | +3.94% | 796,175 |
SNDX | Syndax Pharmaceuticals, Inc. | 21.97 | 0.84 | +3.98% | 1,515,971 |
CGEM | Cullinan Therapeutics, Inc. | 28.10 | 1.09 | +4.04% | 1,275,289 |
AVIR | Atea Pharmaceuticals, Inc. | 3.8500 | 0.1500 | +4.05% | 405,230 |
NVCR | NovoCure Limited | 12.74 | 0.50 | +4.08% | 1,288,461 |
MRNS | Marinus Pharmaceuticals, Inc. | 1.4700 | 0.0600 | +4.26% | 2,281,621 |
FOLD | Amicus Therapeutics, Inc. | 10.43 | 0.44 | +4.40% | 3,980,290 |
EDIT | Editas Medicine, Inc. | 5.47 | 0.26 | +4.99% | 2,566,144 |
ORIC | ORIC Pharmaceuticals, Inc. | 9.33 | 0.50 | +5.66% | 762,455 |
ARQT | Arcutis Biotherapeutics, Inc. | 8.84 | 0.52 | +6.25% | 2,797,077 |
BMEA | Biomea Fusion, Inc. | 11.57 | 0.83 | +7.73% | 1,114,093 |
YMAB | Y-mAbs Therapeutics, Inc. | 16.49 | 1.28 | +8.42% | 365,232 |